NDRAENDRA Life Sciences Inc.

Nasdaq endrainc.com


$ 0.23 $ -0.01 (-5.58 %)    

Friday, 13-Sep-2024 15:46:47 EDT
QQQ $ 474.86 $ 2.12 (0.45 %)
DIA $ 414.87 $ 2.97 (0.72 %)
SPY $ 561.82 $ 2.92 (0.52 %)
TLT $ 100.40 $ 0.27 (0.27 %)
GLD $ 238.66 $ 2.35 (0.99 %)
$ 0.23
$ 0.25
-- x --
-- x --
$ 0.23 - $ 0.25
$ 0.21 - $ 139.50
1,508,847
na
352,925
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-30-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-17-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
17 08-14-2020 06-30-2020 10-Q
18 05-14-2020 03-31-2020 10-Q
19 03-26-2020 12-31-2019 10-K
20 11-13-2019 09-30-2019 10-Q
21 08-08-2019 06-30-2019 10-Q
22 05-14-2019 03-31-2019 10-Q
23 03-11-2019 12-31-2018 10-K
24 11-05-2018 09-30-2018 10-Q
25 08-13-2018 06-30-2018 10-Q
26 05-15-2018 03-31-2018 10-Q
27 03-20-2018 12-31-2017 10-K
28 11-14-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 06-21-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 endra-life-sciences-granted-extension-to-regain-compliance-with-nasdaq-continued-listing-requirements

ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that on Augu...

 endra-life-sciences-q2-2024-gaap-eps-008-misses-004-estimate

ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of...

 endra-life-sciences-announces-alexander-tokman-appointed-as-acting-ceo-to-replace-francois-michelon-who-stepped-down-from-his-role-as-ceo-and-as-a-member-of-the-board-of-directors-to-pursue-other-endeavors-appoints-richard-jacroux-as-cfo

Board Member Alexander Tokman appointed as acting CEO bringing 24+ years of global commercial leadership experienceTwo addition...

 why-endra-life-sciences-stock-is-trading-higher-monday

ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.

 endra-life-sciences-13g-filing-shows-shn-financial-investments-ltd-reported-a-999-stake-in-the-co-as-of-june-4-2024

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION